skip to primary navigationskip to content
 

ilumink bought by technology specialist Tracerco

last modified Mar 06, 2015 01:37 PM
ilumink, which commercialises technology for brand authentication and anti-counterfeiting, has been acquired by industrial technology specialist Tracerco.

 

ilumink is based at ideaSpace West and is a spin-out company from the Department of Engineering at the University of Cambridge. Its approach is underpinned by novel, printed photonic materials created at the university.

Key applications include authentication, anti-counterfeiting and security products with potential markets ranging from high-value consumer goods through to pharmaceuticals. The technology is unique in offering brand owners overt, covert and forensic authentication in one easily applied print feature.

Damian Gardiner, founder of ilumink, said: “My colleagues and I are very much looking forward to becoming part of the Tracerco team. By combining our technical expertise and creativity, we can further develop our world-leading anti-counterfeiting and brand authentication technologies for our customers’ benefit.”

Tracerco is part of the Johnson Matthey Group. The acquisition will further enhance its product assurance portfolio, which is based on innovative and covert marker chemistry coupled with sophisticated analytical platforms.

Dr Vince Croud, Tracerco’s technology director, said: “The acquisition of ilumink will allow us to expand our portfolio of technology offerings to ensure we keep pace with the changing needs of customers. It is an excellent fit with the Tracerco business.”

For more information on the acquisition see the press release here.

RSS Feed Latest news

GeneAdviser partners with Birmingham Women’s Hospital to make personalised medicine more accessible

Sep 29, 2016

The largest genetics laboratory in the NHS brings to the platform their solid tumour sequencing, enabling clinicians to give an individual approach to their patients, tailored to their tumour’s genetic makeup.

GeneAdviser raises £350K to boost uptake of genomic medicine

Jun 02, 2016

GeneAdviser, an online ordering platform for clinical genetic testing, has raised £350,000 in its first round of seed funding, backed by Cambridge biotech angel Dr Jonathan Milner.

ROADMAP Systems secures $1.7m in Series A investment

Apr 08, 2016

ideaSpace member and ROADMap CEO Karl Heeks ready to take revolutionary wavelength switch technology to market

Metrarc wins funding from Innovate UK for data protection research

Mar 31, 2016

Cambridge-based Metrarc is part of a consortium which has won funding worth nearly £400,000 from Innovate UK to combat growing security threats to the management of personal health data.

View all news